To study the effect of Vyaghradi Kashay tablet on COVID-19 patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/10/028570
- Lead Sponsor
- Ministry of AYUSH Govt of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
People who have been tested positive to be infected with SARS-CoV2 virus and presenting with no symptoms or with mild to moderate symptoms.
All the patients of age group 18-65 yrs
All those who are willing to give written consent for participation in the study
COVID patients with symptoms classified as severe or critical.
Persons with severe primary respiratory disease or other pneumonia
Pregnant and lactating women
Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators
COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time taken to be tested negative for SARS-CoV2 in RT-PCR. <br/ ><br>To Assess the effect of drug in preventing the progression of severity of symptoms.Timepoint: a)RT PCR 7th and 14th Day <br/ ><br>b)Assessment of clinical recovery at baseline, Daily 7-14 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method Secondary outcome- <br/ ><br>To assess the effect of Vyaghradi Kwath Tab on blood parameters specific to Covid-19. <br/ ><br>Timepoint: 08-15 days